Tag: rituximab

Unmet needs in the care of patients with neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody associated disease: insights from Germany

Posted by: The Sumaira Foundation in

Real-World Multicenter Cohort Study of Inebilizumab vs Low-Dose Rituximab in Neuromyelitis Optica Spectrum Disorders

Posted by: The Sumaira Foundation in

Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments

Posted by: The Sumaira Foundation in

MOGAD treatment outcomes and relapse characteristics: Real-world experience from a Low-Middle income country

Posted by: The Sumaira Foundation in

Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD

Posted by: The Sumaira Foundation in

Efficacy and safety of rituximab in myelin oligodendrocyte glycoprotein antibody-associated disorders compared with neuromyelitis optica spectrum disorder: a systematic review and meta-analysis

Posted by: The Sumaira Foundation in

Inebilizumab for treatment of neuromyelitis optica spectrum disorder in patients with prior rituximab use from the N-MOmentum Study

Posted by: The Sumaira Foundation in

Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease

Posted by: The Sumaira Foundation in

Tiffany’s NMO Story – Navigating the Navy with NMO

Posted by: The Sumaira Foundation in NMOSD, Patient, Voices of TSF

Tiffany was a military brat with both of her parents serving in the Navy, so joining up herself seemed the obvious choice for her. She enlisted in 2006 and met […]

Bella’s NMO Story – In This Family, We Fight Together

Posted by: The Sumaira Foundation in Caregiver, NMOSD, Voices of TSF

August 29, 2017 will forever be embedded in my mind because it was the day my 9 year old daughter, Bella, woke up sick. It was the day that would […]